Jean Jacques Bienaime
Director · 3 filings · Latest: Apr 15, 2026
Immunome Inc.
Keros Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
KROS | Jean Jacques Bienaime | Director | Apr 15, 2026 | Purchase | $11.70 | 1,000 | $11.7K | 8,450 | |
IMNM | Jean Jacques Bienaime | Director | Mar 11, 2026 | Purchase | $21.55 | 1,000 | $21.6K | 38,415 | |
IMNM | Jean Jacques Bienaime | Director | Mar 10, 2026 | Purchase | $22.12 | 1,000 | $22.1K | 37,415 | |
KROS | Jean Jacques Bienaime | Director | Mar 9, 2026 | Purchase | $11.21 | 2,000 | $22.4K | 7,450 |